





A Novel Oocyte Cryopreservation Method using 
High Pressure Freezing 
 
Brianna Pilbrow  
 
A thesis submitted in partial fulfilment of the degree: 
Bachelor of Biomedical Science with Honours 
(Reproduction, Genetics, and Development).  
 
University of Otago  
Department of Anatomy  




Oocyte cryopreservation (egg freezing) involves freezing a female’s oocytes in order to 
preserve her fertility. These oocytes can later be thawed and fertilised in vitro when she is ready 
to begin fertility treatment. Women rely on this technology to preserve their fertility before 
undergoing gonadotoxic cancer treatment. Oocyte cryopreservation can also be used to delay 
parenthood so that women can pursue higher education and build their careers. This technique 
can also allow the storage and transportation of donor oocytes, making donor eggs accessible 
to more infertile couples.  
 
The current method used for oocyte cryopreservation is termed vitrification. Assisted 
reproduction with vitrified oocytes is inefficient and results in significantly fewer pregnancies 
and live births than those which are achieved using fresh (non-frozen) oocytes. Moreover, 
vitrification causes damage to oocytes, and may result in premature zona hardening. This is 
thought to prevent normal fertilisation and creates a need for fertilisation by intra cytoplasmic 
sperm injection rather than standard in vitro fertilisation which increases costs and can have 
risks. Oocytes are generally vitrified at the mature stage following a two-week hormone 
treatment cycle that stimulates them to mature in vivo. This hormone treatment is 
contraindicated in some patients, including cancer patients with hormone sensitive cancers. 
Immature cumulus oocyte complexes (COCs) can be aspirated directly from the ovaries 
without hormone treatment, however, these COCs must first be stripped of their cumulus cells 
due to the size limitations of vitrification. Vitrification of immature oocytes without their 
cumulus cells is not very successful because the cumulus cells are required for successful 





High pressure freezing (HPF) is a cell preservation technique that has been shown to provide 
superior ultrastructural preservation when compared to conventional vitrification methods and 
has a larger upper size limit that would allow immature COCs to be frozen with their cumulus 
cells intact. This research aimed to determine whether HPF could provide a superior oocyte 
cryopreservation method compared to vitrification and allow immature COCs to be frozen and 
retain their developmental capacity.  
 
Immature and in vitro matured sheep oocytes were frozen using either HPF (N = 164) or a 
conventional vitrification method (N = 270). Groups of frozen oocytes were then thawed, in 
vitro matured (where appropriate), in vitro fertilised, and cultured for 8 days to compare oocyte 
recovery after thawing, oocyte cleavage, and embryo development. Another group of oocytes 
were thawed, fertilised, and stained using DAPI to visualise pronuclei and sperm attached to 
the zona in order to compare fertilisation status and determine whether the zona reaction had 
occurred prematurely or not. Finally, the remaining oocytes were thawed, in vitro matured, 
fixed, embedded, and sectioned to observe their ultrastructure under a transmission electron 
microscope.  
 
Recovery rates after thawing were significantly lower in HPF oocytes compared with vitrified 
oocytes (P=0.001), as were cleavage rates (P<0.001). DAPI staining showed that neither HPF 
nor vitrified oocytes were affected by polyspermy as no extra nuclei were present after 
fertilisation. Furthermore, all fertilised oocytes had sperm bound within their zona pellucida, 
indicating that the zona reaction had not occurred prematurely. Ultrastructural investigation 
using transmission electron microscopy showed that there were no striking differences between 




damage including an absence of cortical granules and evidence of vesicle coalescence and 
enlargement.  
To conclude, high pressure freezing did not improve oocyte developmental capacity or 
ultrastructural preservation after freezing, however, further research is required to determine 
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1 Introduction  
1.1 What is oocyte cryopreservation?  
Oocyte cryopreservation is a fertility preservation technique that involves harvesting a female’s 
oocytes from her ovaries and freezing them (unfertilised) using liquid nitrogen so that they may 
be stored until she is ready to become pregnant (Leibo et al., 2011). In 2013, the technology 
was deemed no longer experimental (Ethics Committee of the American Society for 
Reproductive Medicine, 2013) as it seemed that pregnancy rates achieved using in vitro 
fertilisation (IVF) or intra cytoplasmic sperm injection (ICSI) to fertilise frozen-thawed 
oocytes were approaching those achieved using fresh oocytes. Furthermore, although data are 
limited, existing studies have reported no increase in the number of chromosomal 
abnormalities, birth defects, or developmental defects occurring in babies conceived using 
frozen-thawed oocytes as opposed to fresh (non-frozen) ones (Ethics Committee of the 
American Society for Reproductive Medicine, 2013; Noyes et al., 2009).  
 
There are several key reasons why women may wish to freeze their eggs. Fertile women may 
choose to do so in order to delay childbirth until a later date and extend their ‘window of 
opportunity’ to conceive (Borini et al., 2010). Oocyte cryopreservation can also be used to help 
female cancer patients preserve their fertility (Brambillasca et al., 2013; Combelles et al., 2012; 
Dolmans et al., 2019). Chemotherapy and radiation can be gonadotoxic and often lead to 
premature ovarian failure (Anderson et al., 2006; Bath et al., 2003; Bines et al., 1996). Women 
are surviving their cancer more and more often, only to go on to battle with infertility. Studies 
have shown that patients are more emotionally equipped to cope with “tough treatments” when 
they know there is a chance that they may be able to have a biological child in the future 
(Partridge et al., 2004). Oocyte cryopreservation is also valuable for storing donor eggs for 
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assisted reproduction as it eliminates the need to synchronise the menstrual cycles between the 
oocyte donor and the recipient (Borini et al., 2010). Oocyte cryopreservation can also be used 
to ‘save’ excess oocytes from an ovarian stimulation cycle when only one oocyte can be 
fertilised and implanted per cycle, or when sperm is not available on the day of retrieval. 
Moreover, oocyte cryopreservation can help circumvent legal or moral issues in societies 
where it is not acceptable to freeze embryos but oocytes can be frozen (Borini et al., 2010). 
Although this technique is being used routinely, assisted reproduction using cryopreserved 
oocytes is inefficient and results in significantly fewer pregnancies and live births than what is 
achieved using fresh (non-frozen) oocytes (Borini et al., 2010; Kushnir et al., 2018). Moreover, 
this treatment is not accessible to a significant proportion of women for whom the hormone 
treatment required to retrieve oocytes is contraindicated. There is a pressing need to develop a 
more efficient method that results in consistently higher cleavage rates, blastocyst formation 
rates and pregnancy rates, as well as a method that does not require hormone treatment and can 
meet the needs of more women.  
 
1.2 Oogenesis and folliculogenesis  
Female fertility depends on the ovulation of a mature, developmentally competent oocyte that 
possesses the ability to support fertilisation, preimplantation embryo development and fetal 
development until the birth of a healthy baby (Gilchrist, 2010). This oocyte must be ovulated 
into the fallopian tube at the appropriate time when the uterine lining is capable of supporting 
a pregnancy, and must be fertilised within 24 h of ovulation. Human females are born with a 
finite pool of primordial follicles which contain all of the oocytes that she will ever have 
(McGee et al., 2000). These primordial follicles must mature into primary, secondary, and 
eventually antral follicles under the control of paracrine and endocrine signalling, as is shown 
in Figure 1-1. At the antral follicle stage, most follicles undergo atresia and are degenerated. A 
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pool of antral follicles are recruited or ‘saved’ from atresia each month to undergo further 
maturation to the pre-ovulatory stage seen in Figure 1-1, at which point the oocytes contained 
within the follicles become mature. In humans, generally only one follicle reaches the pre-
ovulatory stage each month. This follicle is thought to be the highest quality follicle, however 
little is known about oocyte and follicle quality and how this is determined. Oocyte quality 
refers to an oocytes developmental capacity, or ability to support fertilisation and embryonic 
development. In assisted reproduction this is often measured by cleavage rates, blastocyst 
formation rates, pregnancy rates and live birth rates.  
 
Follicle stimulating hormone (FSH) signalling drives dominant follicle selection and 
eventually the luteinising hormone (LH) surge causes a decline in gap junctions through which 
the oocyte and its surrounding cumulus cells communicate. This leads to the dissociation of 
mural granulosa cells and the expansion of the cumulus cells surrounding the oocyte. In the 
absence of communication from the cumulus cells, the oocyte resumes meiosis as the cumulus 
cells were previously providing the signalling factors preventing the resumption of meiosis. 
This LH surge therefore induces the resumption of meiosis to create a mature oocyte, forming 
a polar body and as the follicle and oocyte maturation is complete, the LH surge also induces 
ovulation. The oocyte contained within the dominant follicle is ovulated with its cumulus cells, 
leaving behind the granulosa and theca cells which form a corpus luteum on the external surface 




Figure 1-1. Diagram of folliculogenesis adapted from (Silber, 2019). Females are born with 
all of their oocytes in primordial follicles. These follicles progress through various stages of 
maturation until the antral follicle stage, at which point the majority undergo atresia. Each 
month one to two follicles are ‘saved’ from atresia, continue maturing to the preovulatory stage 
and release their oocyte into the fallopian tube during ovulation. This happens in response to 
the LH surge. A corpus luteum then forms from the remaining follicle cells on the external 
surface of the ovary, indicating that ovulation has taken place. 
When oocyte-cumulus cell communication is interrupted prematurely, the oocyte is less likely 
to mature successfully as the intricate control of maturation and folliculogenesis is disrupted 
and the oocyte does not receive the key signalling factors it needs to mature successfully. 
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Cumulus cell factors are critical for oocyte survival, capacitation, and successful fertilisation. 
They are required to maintain developmental capacity (Hosseini et al., 2012; Sirard, 2012). For 
example, oocytes are not able to metabolise glucose on their own, they rely on the transport of 
glucose metabolites from the cumulus cells through gap junctions in order to have sufficient 
energy sources to drive their mitochondria (Johnson et al., 2007). Studies have shown that 
ovulation does not occur in the absence of these gap junctions (Simon et al., 1997) and this is 
likely an innate quality control system to prevent the ovulation of a poor quality oocyte that is 
not likely to lead to a healthy pregnancy. Maternal oocyte-derived factors such as mRNA 
transcripts, proteins, energy providing substrates and cytoplasmic organelles (in particular 
mitochondria) facilitate early mitotic divisions until embryonic genome activation occurs 
around three days after fertilisation (Hosseini et al., 2016).  
 
1.3 Oocyte maturation and fertilisation   
The timing of oocyte maturation, ovulation, and fertilsation are extremely important and these 
processes are tightly linked (Robker et al., 2018). As seen in Figure 1-2, the oocyte membrane 
(oolemma) encloses all of the oocyte, the organelles within the cytoplasm and the oocyte is 
surrounded by the zona pellucida. The space between the oolemma and the zona pellucida is 
called the perivitelline space and microvilli from the oolemma project into the perivitelline 
space. During oocyte maturation, cortical granules line up immediately underneath the 
oolemma as can be seen in Figure 1-3 so that they can release their contents into the 
perivitelline space upon binding by sperm of the oolemma (Sathananthan et al., 1982). This 
exocytosis of cortical granules induces the zona reaction which causes the inner surface of the 
zona pellucida to harden, blocking any further sperm from penetrating the zona pellucida and 
preventing polyspermy from occurring. Successful fertilisation requires this  polyspermy block 
to prevent more than one sperm from penetrating the oocyte (Liu, 2011). In the immature 
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oocyte, mitochondria are round in shape and are distributed in small clusters in the ooplasm. 
During maturation, the proportion of hooded mitochondria which are thought to be more active 
than normal mitochondria increases and all of the mitochondria become distributed evenly 
throughout the ooplasm (Reader et al., 2015). This is important because after fertilisation the 
cell must be able to keep up with the high energy demands of early embryonic development 
and when the cell starts dividing, all of the resulting cells must receive ample active 
mitochondria to support early embryonic development (Brambillasca et al., 2013).  
 
Cumulus cell expansion and the production of hyaluronic acid by the cumulus cells are also 
important for fertilisation and sperm binding. The acrosome reaction allows sperm to penetrate 
the zona pellucida so that the gamete membranes can fuse and this requires hyaluronic acid 
which is produced by the cumulus cells (Gutnisky et al., 2007). Hence, in the absence of 
cumulus cell secretions, fertilisation capacity is reduced. In the presence of hyaluronic acid, 
the acrosome reactions occurs allowing the sperm to penetrate the zona pellucida and bind to 
the oolemma. The spermatozoa nuclear envelope then breaks down and the sperm head is 
decondensed so that the male nucleus can enter the oolemma and form a male pronuclei 

















Figure 1-2. (above) Transmission electron microscope images of sheep oocytes before and 
after in vitro maturation. (a) Immature cumulus oocyte complex before IVM containing the 
immature oocyte and oolemma, perivitelline space (pv) and zona pellucida (zp) with compact 
layers of cumulus cells (cc) surrounding it. These are connected to the oocyte through gap 
junctions. The organelles including mitochondria and cortical granules are distributed evenly 
throughout the ooplasm. (b) A COC oocyte after IVM. The cumulus cells have expanded and 
are no longer connected to the oocyte through gap junctions. The first polar body (pb) has been 
extruded and can be seen in the perivitelline space, indicating that the oocyte has undergone 
the first meiotic division. Cortical granules (small black arrows) are abundant immediately 
under the oolemma ready to undergo exocytosis and release their contents into the perivitelline 
space upon penetration of the zona pellucida by the first sperm during fertilisation. 




Figure 1-3. (below) Transmission electron micrographs of sections of the zona pellucida and 
outer ooplasm of a sheep COC after IVM. (a) and (b) show the abundance of cortical granules 
(white arrows) found immediately underneath the oolemma of mature oocytes. Mitochondria 
(black arrows), including hooded mitochondria (black arrow, *) that are more abundant in 
mature oocytes than immature oocytes can also be seen as well as vesicles (V) and lipids (L).  
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1.4 Current oocyte cryopreservation methods  
Human oocytes are one of the largest cells of the body and have a very low surface area to 
volume ratio, which makes them difficult to successfully freeze as they are vulnerable to ice 
crystal damage (Borini et al., 2010). Originally, slow rate cooling methods were used for oocyte 
cryopreservation, however, the birth of a new vitrification (rapid cooling) method has increased 
the success rates of assisted reproduction using cryopreserved oocytes (Chian et al., 2017). 
This rapid cooling method is considered to be superior to slow rate cooling in the majority of 
the literature (Kamath et al., 2017; Muthukumar et al., 2013). Vitrification involves the ultra-
rapid cooling of mature oocytes with the use of high concentrations of cryoprotectant in order 
to preserve oocytes in a glass-like state and prevent the formation of ice crystals (Roy et al., 
2017).  
 
There are several different protocols that are used for vitrification in the clinical setting. The 
most common of these are solid surface vitrification and vitrification in a cryotube. The solid 
surface method involves direct contact of the fibre plug carrier containing the oocyte in a media 
droplet with a precooled metal block (Nagy et al., 2017). The cryotube method involves loading 
oocytes onto a carrier within a plastic cryotube and plunging the cryotube directly into liquid 
nitrogen (LN2) (Nagy et al., 2017). Although the cryotube method is sometimes favoured due 
to avoiding direct contact with the LN2 which prevents cross contamination between samples, 
it requires a very low volume of media (<0.2 µl) to achieve sufficiently rapid cooling and 
warming rates (Bagis et al., 2004). This is because the plastic cryotube creates an isolating 
layer between the sample and the LN2. The solid surface method allows a more rapid cooling 
and warming rate as heat exchange is improved due to the direct contact of the cooled block 
with the media containing the oocyte.  
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There are three key variables that influence the oocyte’s chance of survival and developmental 
success after cryopreservation; cryoprotectant concentration and permeability, rate of cooling 
and rate of warming. Leibo and colleagues showed that oocytes must be cooled and warmed 
rapidly during cryopreservation in order to survive and go on to develop successfully (Leibo 
et al., 2011). Moreover, they showed that a rapid warming rate is equally critical, if not more 
critical than a rapid cooling rate. Cryoprotectants can be cytotoxic at high concentrations, 
however, without cryoprotectants extensive ice crystal formation occurs which leads to cell 
rupture (Rienzi et al., 2017; Roy et al., 2017). Vitrification protocols where the oocyte is 
exposed to lower concentrations of cryoprotectant for a longer period of time in order to 
equilibrate, replacing the water with cryoprotectant and then exposed to high concentrations of 
cryoprotectant very briefly for less than 30 s to ensure that all of the water is drawn out of the 
cell have proven successful at minimising cytotoxicity as well as ice crystal damage (Kamath 
et al., 2017; Leibo et al., 2011).  
 
Although some argue that the success rates of assisted reproduction using vitrified oocytes are 
comparable to those achieved using fresh (non-frozen) oocytes (Chian et al., 2017; Goldman 
et al., 2013), there is evidence that the blastocyst formation rate, implantation rate, live birth 
rate per oocyte retrieved, and live birth per embryo transferred are all reduced when performing 
assisted reproduction with vitrified oocytes (Goldman et al., 2013; Kushnir et al., 2018). These 
findings suggest that cryopreserved oocytes are of poorer quality and have reduced 
developmental capacity compared to fresh oocytes.  
 
1.5 Limitations of vitrification method 
Regardless of how successful or not the current methods for mature oocyte cryopreservation 
are, these methods are not appropriate for all women and many women who could benefit from 
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oocyte cryopreservation are not able to access this treatment. Currently, the vitrification of 
mature oocytes requires women to undergo a round of controlled ovarian stimulation in order 
to harvest mature oocytes to freeze (Chian et al., 2017; Combelles et al., 2012). This ovarian 
stimulation involves treatment with gonadotrophins to stimulate ovarian and follicular growth 
and maturation in vivo, which can take up to two weeks. Many cancer patients need to start 
their cancer treatment immediately in order to have the best prognosis and cannot delay this in 
order to retrieve oocytes to freeze. Furthermore, women with hormone sensitive cancers such 
as breast cancer cannot undergo ovarian stimulation as this could stimulate growth of the cancer 
(Chian et al., 2017). Ovarian stimulation can also cause ovarian hyper stimulation syndrome in 
some women which is associated with pain, bleeding, vomiting, and infection. Women who 
experience hyperstimulation syndrome cannot continue ovarian stimulation treatment (Chian 
et al., 2017).  
 
Although it is currently possible to avoid ovarian stimulation and retrieve immature oocytes 
directly from the developing follicles in the ovary, immature oocytes must be matured in vitro 
before they can be fertilised and human in vitro maturation of vitrified-warmed oocytes is 
inefficient (Chian et al., 2017; Gilchrist, 2010).  
 
1.6 How does oocyte vitrification affect the oocyte?   
It has been shown that the highly ordered structure of the oocyte incurs notable damage after 
cryopreservation at the cellular, ultrastructural, and molecular levels (Asgari et al., 2011; 
Bernard et al., 1996; Fabbri et al., 2001; Potdar et al., 2014; Saragusty et al., 2011) and this 
could explain why frozen-thawed oocytes tend to demonstrate reduced developmental capacity 
compared to fresh oocytes and result in fewer live births per embryo transferred in a clinical 
setting (Kushnir et al., 2018). Often mitochondria are damaged during cryopreservation, losing 
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their round shape and becoming swollen. The redistribution of mitochondria after oocyte 
maturation is also affected by oocyte cryopreservation (Hosseini et al., 2016). There is evidence 
that the perivitelline space of the oocyte is enlarged, and the number of associated microvilli 
projecting into it are reduced after oocyte cryopreservation (Asgari et al., 2011; Bernard et al., 
1996). There is also evidence that cortical granules undergo premature exocytosis during the 
cooling or warming steps of vitrification (Porcu et al., 1997). This results in the premature 
release of the contents of cortical granules causing the inner-surface of the zona pellucida to 
harden (Polak de Fried et al., 1998). This zona hardening reduces the capacity of the oocyte to 
support normal fertilisation. Studies have reported low rates of successful fertilisation and 
development after IVF of cryopreserved oocytes due to zona hardening and subsequently 
intracytoplasmic sperm injection (ICSI) is routinely used to fertilise cryopreserved oocytes 
rather than conventional IVF (Hosseini et al., 2016; Porcu et al., 1997).  
 
1.7 Cryopreservation of immature oocytes  
Mature oocytes are retrieved for cryopreservation after a 2-week hormone treatment to 
stimulate in vivo oocyte maturation (Borini et al., 2010; Chian et al., 2017). In these oocytes, 
the metaphase chromosomes are lined up along the equatorial plate by the meiotic spindle. 
According to studies (Shaw et al., 2000, Baka et al., 1995), the meiotic spindle apparatus in 
mature oocytes is susceptible to damage from intracellular ice formation during oocyte 
cryopreservation thus it would be advantageous to cryopreserve immature germinal vesicle 
stage oocytes whose nuclei are less vulnerable as they form the germinal vesicle. Moreover, 
controlled ovarian stimulation to retrieve mature oocytes is contraindicated for many women, 
as discussed above.  
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It is currently possible to retrieve and cryopreserve immature oocytes successfully after in vitro 
maturation, avoiding the hormone treatment, however, the clinical outcomes including 
blastocyst formation rate and live birth rate when doing this do not reach that achieved when 
cryopreserving mature oocytes (Chian et al., 2014). This may be because in vitro maturation 
does not work very well in human oocytes, particularly after cryopreservation. It seems that 
the potential for successful oocyte maturation is reduced when immature oocytes are retrieved 
and vitrified (Chian et al., 2017) which is likely due, at least in part, to the loss of the cumulus-
oocyte communication discussed below.  
 
As is discussed above, immature oocytes are dependent on their cumulus cells for maturation, 
capacitation and fertilisation. Together the oocyte and its cumulus cells make up the cumulus-
oocyte complex (COC). The COC is larger (200 microns) than the maximum size limit of 
conventional vitrification methods and thus immature COCs cannot be cryopreserved using 
vitrification. In order to freeze immature oocytes using standard vitrification methods, the 
cumulus cells must be removed however, this leaves the oocyte without critical energy sources, 
substrates and signals that it needs from the cumulus cells to mature normally and support early 
embryonic development. Removing the cumulus cells for vitrification decreases the chances 
that the oocyte will be able to develop to the blastocyst stage for implantation. Moreover, the 
removal of the oocytes’ support cells may reduce fertilisation rates following standard IVF 
protocols due to zona pellucida hardening  (Gook et al., 1994) and possibly due to a loss of 
hyaluronic acid to induce the acrosome reaction.  
 
1.8 High pressure freezing  
Studies have suggested that freezing large cells such as oocytes at ambient pressure leads to 
ice crystal formation and related damage (Kaech et al., 2014). A paper by Huebinger and 
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colleagues looked at a self-pressurised rapid freezing approach for mammalian cell 
cryopreservation and, although this study did not examine oocytes, it did suggest that adding 
in a high pressure component to the vitrification process could improve cryopreservation 
(Huebinger et al., 2016). High pressure freezing (HPF) involves rapid freezing of samples using 
liquid nitrogen under 2000 bar of pressure. Samples are mounted into a small gold-coated 
copper disc within a cartridge that is guided automatically through the freezing process until it 
is immersed in liquid nitrogen. This cartridge optimises the flow of liquid nitrogen to the 
sample, ensuring ultra-rapid cooling and the processes is automated, ensuring that the samples 
are frozen instantly, eliminating the human error that is associated with manual vitrification. 
HFP has been shown to provide superior ultrastructural preservation compared with other 
preservation methods (Huebinger et al., 2016). This method could be utilised for oocyte 
cryopreservation to preserve the ultrastructure of oocytes.  Moreover, HPF has a higher upper 
size limit than conventional vitrification methods, and could therefore be used to cryopreserve 
large immature cumulus oocyte complexes with the cumulus cells still intact. HPF was patented 
in 1987 (Conaway, 1987) as a method for cryopreserving cells and tissues including oocytes, 
sperm, and embryos yet there have not yet been any publications showing that this can be done.  
 
In 2017, Dr Karen Reader from my research group performed a pilot study to assess whether 
HPF could be used to preserve viable oocytes. The data from this study confirmed that oocytes 
could survive HPF and showed that HPF lead to higher cleavage rates in both mature and 





Table 1-1. Recovery, cleavage, and development data from the pilot study (Reader, 
unpublished).  
 Unfrozen  COC  MO 
  HPF Vit  HPF  Vit  
Number thawed  - 13 15 11 16 
Number Recovered  - 9 14 8 14 
Number Intact  40 7 13 6 14 
Number Cleaved  36 4 3 4 6 
Cleavage % intact  90% 57% 23% 67% 43% 
Blastocyst %  28%  0% 0% 0% 0% 
 
What was even more promising from this preliminary study was the transmission electron 
microscopy investigation. HPF oocytes, vitrified oocytes, and HPF oocytes without 
cryoprotectant were freeze substituted and examined under transmission electron microscopy 
(TEM). The freeze substitution involved slowly warming the oocytes over a period of several 
days whilst simultaneously infusing them with a fixative. As seen in Figure 1-4a and 1-4d, the 
cytoplasm and zona pellucida of oocytes HPF with no cryoprotectants had excellent 
ultrastructure consistent with that of a fresh-fixed oocyte and was therefore used as a control. 
The oocytes that were vitrified and HPF with cryoprotectants can then be compared. Figure 1-
4b and 1-4c show that the cytoplasm of the vitrified oocyte appears to be affected by enlarged 
and coalescing vesicles, enlarged lipids and disruption to the microvilli penetrating the 
perivitelline space which do not affect the HPF oocyte. The zona pellucida preservation is also 
superior in HPF oocytes compared to vitrified ones, as can be seen in Figure 1-4e and 1-4f. 
The vitrified zona pellucida has pores which were not apparent in the HP frozen oocytes.   
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Figure 1-4. Transmission electron micrographs comparing the preservation of the cytoplasm 
and zona pellucida in HPF and vitrified oocytes containing cryoprotectants to that of HPF 
oocytes that did not contain cryoprotectants after freeze substitution. (a)The cytoplasm of a 
HPF oocyte with no cryoprotectant. This cytoplasm has excellent ultrastructure consistent with 
that of a fresh-fixed oocyte and is therefore used as a control. The vesicles (V) and lipids (L) 
can be seen as well as mitochondria (black arrows). (b) The cytoplasm of a HPF oocyte with 
cryoprotectants. Although the cytoplasm is stained darkly due to the presence of 
cryoprotectants, the ultrastructure of the oocyte appears to be conserved well. There is minimal 
coalescing of the Vesicles (V) and enlargement of lipids (L). (c) The cytoplasm of a vitrified 
oocyte stained darkly due to the cryoprotectants. Significant enlargement and coalescing of the 
vesicles and lipids can be seen, indicating damage to the oocyte due to the vitrification process. 
(d) The zona pellucida of a HPF oocyte with no cryoprotectants has excellent ultrastructure 
comparable to that of frozen-fixed oocytes and is therefore used as a control. (e) The zona 
pellucida of a HPF oocyte with cryoprotectants also has excellent ultrastructure with no 











cryoprotectants has substantial pores and has not been preserved. Top panel scale bar 1 µm, 
bottom panel scale bar 2 µm.     
 
The results from this pilot study are promising and suggest that HPF could in fact be used to 
improve assisted reproduction outcomes using cryopreserved oocytes. However, low numbers 
were used for this study and only one in vitro embryo production (IVP) experiment was 
conducted with no repeats so these results may not be reproducible.  Furthermore, the oocytes 
frozen for this study were freeze-substituted and this does not therefore allow the observation 
of oocytes after warming and in vitro maturation.  Further research is required with greater 
numbers of oocytes and multiple repeats of the IVP experiments to confirm whether HPF could 
improve recovery rates after cryopreservation and thawing as well as cleavage rates and 
blastocyst formation rates.  
 
1.9 Aim hypothesis and objectives  
Further research is required in the oocyte cryopreservation field to improve the efficiency of 
assisted reproduction using cryopreserved oocytes and to develop a method that would allow 
the successful cryopreservation of both mature and immature oocytes. HPF is a promising 
method that could be used to improve ultrastructural preservation during oocyte 
cryopreservation. This could lead to increased recovery, cleavage and blastocyst formation 
rates. The aim of this project is to compare the developmental capacity, fertilisation status and 
ultrastructural preservation of immature and mature oocytes after vitrification and high 
pressure freezing. I hypothesize that high pressure freezing will provide a superior oocyte 
cryopreservation technique and that HPF oocytes will demonstrate increased developmental 
capacity compared with vitrified oocytes.  
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In order to test the hypothesis, there were three main objectives:  
 
1. To compare the developmental capacity of vitrified oocytes to that of HPF oocytes by 
assessing their ability to support fertilsation, to cleave, and to develop to the blastocyst 
stage after IVF.  
 
2. To compare the fertilisation status of oocytes that have been fertilised in vitro after 
vitrification or HPF in order to determine whether the zona reaction is happening 
normally. This will be achieved by counting the nuclei present in the ooplasm after in 
vitro fertilisation and examining the zona pellucida for sperm trapped within.  
 
3. To compare the ultrastructure of vitrified and HPF mature oocytes after 
cryopreservation, thawing, and in vitro maturation (IVM) using transmission electron 




2 Materials and Methods 
The Ngai Tahu Research Consultation Committee were consulted when planning these 
experiments in accordance with the ‘Policy for Research Consultation with Maori’ in Aotearoa. 
This project was laboratory based and used abattoir derived tissue from sheep, therefore no 
further consultation was recommended.  
 
2.1 In vitro embryo production experiments  
A list of ovine in vitro embryo production (IVP) media recipes can be found in Appendix A. 
In order to maintain sterility for these experiments, all media preparation was carried out under 
a laminar flow hood. All media was made with a pH of 7.4 and stored at 4 °C. In vitro 
maturation (IVM) media, in vitro fertilisation (IVF) media, hepes buffered synthetic oviduct 
fluid (HSOF) and synthetic oviduct fluid (SOF) were supplied by AgResearch (Ruakura, NZ). 
All incubation for IVM was performed in a 38.5°C, 5% CO2 (CO2 gas) incubator. All 
incubation for IVF and in vitro embryo culture was performed in a 38.5°C, 5% CO2, 7% O2, 
88% N2 (low oxygen) incubator. IVM, IVF and IVC plates were made up with their media and 
equilibrated at a temperature of 38.5°C in an appropriate incubator and gas environment for a 
minimum of 2 h before oocytes were added. This temperature was used to mimic the internal 
body temperature of sheep which is between 38 and 39 °C. Media drops were overlaid with 
mineral oil (Sigma) in order to prevent the evaporation of the media, allow the gas to permeate 
the media and to limit contamination. Embryo and oocyte work was carried out on heating 
plates set to 38.5 °C. The IVP protocols in this thesis are based on successful embryo culturing 
protocols that have been previously established, with the intention of replicating the in vivo 
oviduct environment to give the best chances of successful fertilisation and development to the 
blastocyst stage (Reader et al., 2015).  
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2.1.1 Oocyte retrieval  
In order to obtain ovine oocytes for these experiments, ovaries were retrieved from the 
reproductive tracts of adult ewes from Silver Fern Farms Ltd Finegand plant meat works, stored 
in insulated flasks containing prewarmed 0.9% saline between 30°C and 37°C, and transported 
back to the lab within 3 h of retrieval. Upon arrival they were rinsed with 70% ethanol also at 
38°C and washed in warm 0.9% saline at 38 °C at least 3 times in order to sterilise the external 
surface before aspiration. Immature cumulus oocyte complexes (COCs) were aspirated from 
the visible antral follicles in these ovaries using a 20 g needle and 10 ml syringe containing 
aspiration media constituting hepes buffered M199 media (H199) containing heparin, and 
bovine serum albumin (see Appendix A) as previously described by (Reader et al., 2015). At 
this point, COCs were left in 15 ml Falcon tubes in a dry bath set to 38.5°C for 5 min in order 
to settle to the bottom of the tube.  Only antral follicles greater than 2 mm in diameter would 
be visible to be aspirated and these antral follicles contain fully grown COCs.  Oocytes were 
not aspirated from larger pre-ovulatory follicles as these may have contained mature oocytes.  
 
The abattoir is located 84 km away from the lab and it takes approximately 1 h and 20 min to 
drive between the two. Moreover, due to collecting large quantities of oocytes on each 
collection (approximately 80), aspirating oocytes took approximately 1 h upon returning to the 
lab before the oocytes were placed into base media and either cryopreservation or IVM 
procedures began. Due to this, there was a delay of between 2.5 and 3 h after slaughter before 




2.1.2 In vitro maturation  
In preparation for IVM, IVM plates were made up with 40 µl drops of IVM medium 
(constituting maturation media and cysteamine from Ruakura, NZ, see appendix A) and 
covered with 8 ml of mineral oil (Sigma, Auckland, New Zealand) in a 60 mm non-tissue 
culture treated Falcon petri dish. These were incubated in the CO2 incubator before oocytes 
were added to the IVM drops. It was important to use non-tissue-culture treated petri dishes 
for IVP work, as otherwise the media drops containing the oocytes would not remain in place 
in their dish.  
 
After aspiration, the sediment from the bottom of each aspiration tube containing the COCs 
(approximately 1 ml) was transferred into a pre-warmed (38.5°C) 90 mm petri dish with a 1 
cm square grid drawn underneath, containing fresh aspiration media. A Nikon SM21000 
stereomicroscope and an Omron Labtronics heating stage (Coherent Scientific, Auckland, NZ) 
were used to view the dish and search for the COCs square by square. The COCs were 
transferred to a 35 mm petri dish containing prewarmed (38.5°C ) H199+10%FCS.  
 
Next the oocytes were selected under the Nikon SM21000 stereomicroscope at 20x or 40x 
magnification. The COCs that were light in colour, had an evenly granulated cytoplasm and 
were completely surrounded by a corona of unexpanded cumulus cells were picked up and 
transferred to a second 35 mm petri dish (prewarmed to 38.5°C) containing H199+10%FCS 
and then a third 35 mm petri dish (prewarmed to 38.5°C) containing bicarbonate buffered 
M199 (B199) +10%FCS and were then immediately transferred into previously prepared and 
equilibrated IVM dishes. Ten COCs in 10µl of B199+10%FCS were transferred into each 40 
µl drop of IVM media. Once all of the COCs were in IVM drops, the IVM dishes were 




2.1.3 Sperm and plate preparation for IVF  
First, IVF media was made by adding 2 ml heat inactivated day 1.5 post oestrous sheep serum 
and 100 µl of Penicillamine/Hypotaurine to 8 ml IVF media. 30 µl drops of sterile IVF medium 
were added to a 60 mm non-tissue-culture treated petri dish and covered with 8ml Sigma 
mineral oil at room temperature before being placed into a low oxygen (7%) incubator.  
 
Bovipure gradient separation of motile sperm was performed under a Captair RNA/DNA 
laminar flow hood (Erlab Gallay Medican and Scientific Pty Ltd) to maintain sterility. This 
was prepared by overlaying 40% Bovipure over 80% Bovipure (Appendix B) in a 15 ml 
centrifuge tube, as shown in Figure 2-1.  
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Figure 2-1. Diagram of the density gradient centrifugation process. This separates motile, 
morphologically normal spermatozoa from non-motile abnormal spermatozoa, seminal 
plasma, white blood cells, and debris based on their density, resulting in a pellet of viable, 
motile sperm. Figure sourced from Malvezzi et al., 2014. 
 
Next, a straw of frozen ram semen (Genetic Gains Ltd, Wanaka, NZ) was collected in a flask 
of liquid nitrogen and thawed in the water bath for one minute before being overlaid on the 
Bovipure gradient.  Several drops of the semen were dropped onto a prewarmed slide and the 
sperm were observed under an Olympus 412 stereomicroscope (Olympus corporation, Tokyo, 
Japan) to ensure the sperm motility at post-thaw was at least 50%, based on observation. If this 
was the case, a sterile glass Pasteur pipette was used to aspirate the thawed semen and gently 
layer it on top of the Bovipure gradient as seen in Figure 2-1.  
 25 
 
The tube containing the Bovipure gradient and sperm was then centrifuged at 700g for 20 min 
using an Eppendorf Centrifuge 5430 (Eppendorf, Hamburg, Germany). Immediately after the 
centrifuge came to a halt, the sperm pellet containing motile, morphologically normal 
spermatozoa at the bottom of the centrifuge tube was carefully removed and transferred into 
the tube containing 1 ml of hepes buffered synthetic oviduct fluid (HSOF) at room temperature. 
This was centrifuged at 200g for 5-10 min before being resuspended in 200 µl of equilibrated 
IVF medium. It was important to remove the sperm pellet immediately after each centrifugation 
step so that the motile sperm did not swim back through the gradient. Sperm were counted on 
a haemocytometer using standard counting methods and diluted to provide a final sperm 
concentration of 2 million sperm per ml in the IVF drop.  
 
2.1.4 In vitro fertilisation  
Oocytes were removed from IVM drops after 22-26 h of maturation and transferred to a 35 mm 
petri dish containing pre warmed (38.5°C) HSOF. A 1 ml pipette set to 500 µl was then used 
to pipette the oocytes up and down to gently loosen the expanded cumulus cells to assist with 
fertilisation. The oocytes were then washed in prewarmed (38.5°C) HSOF, washed in 
prewarmed (38.5°C) IVF media and finally, 5 oocytes at a time were transferred in 10 µl of 
IVF medium into each 30 µl IVF drop. The plates were then returned to the low oxygen 
incubator.  
 
Once the sperm preparation was complete, 10 µl of diluted sperm (2million sperm/ml) were 
added to each 40 µl IVF drop containing the oocytes, creating a one to four ratio of sperm to 
oocytes and the plates were returned to the low oxygen incubator for 18-24 hours. A low 
oxygen environment was used for fertilisation and embryo culture in order to replicate the in 
 26 
vivo oviduct and uterine environment of sheep. There is evidence that under 5 % oxygen 
conditions, a higher proportion of fertilised oocytes will develop to the blastocyst stage by day 
6 post fertilisation compared to those fertilised and cultured at 21% oxygen. This indicates that 
they are of higher quality (Leoni et al., 2007).   
 
2.1.5 In vitro culture system for sheep embryos  
In order to prepare IVC plates for embryo culture, 20 µl media drops of SOF were made around 
the outside of a 35 mm petri dish, a 40 µl wash drop was made in the centre and the dish was 
covered with 3 ml Sigma mineral oil and equilibrated in the low O2 incubator. 5 ml of fresh 
HSOF for washing embryos was placed in the low O2 incubator to be pre-warmed (38°C).  
 
18-24 hours after IVF, embryos were removed from their IVF drops using a sterile filter pipette 
tip and transferred to a 35 mm petri dish of fresh, prewarmed HSOF. A pulled Pasteur pipette 
on the end of a mouth pipette was used to pick up the embryos and transfer 60-90 of them to 
the central wash drop of the IVC plate. 10-15 embryos were then transferred to each 20 µl 
culture drop and the plates were returned to the low O2 incubator.  
 
After 5 d in culture, fresh culture plates were prepared as above and embryos were transferred 
to a central wash drop on a new plate and into culture drops, leaving the uncleaved oocytes 
behind in the central wash drop. The embryos were observed under a Nikon SM21000 
stereomicroscope (Nikon, Tokyo, Japan) and an Omron Labtronics heating stage (Omron, 
Kyoto, Japan).  on days 5, 6, 7 and 8 post-fertilisation the number of embryos at each stage of 
development seen in table 2-1 was recorded based on the Manual of the International Embryo 
Transfer Society (Stringfellow and Seidel, 2006).  
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Table 2-1. List of stages of embryo development 
Stage Description  
1 Unfertilised oocytes  
2 2-12 cell embryo   
3 Early morula  
4 Compacted morula  
5 Early blastocyst  
6 Blastocyst 
7 Expanded blastocyst  
 
The proportion of each group of fertilised oocytes that were unfertilised (stage 1), cleaved 
(stages 2 or later) and that developed to the blastocyst (stages 6 and 7) were used to generate a 
cleavage rate and a blastocyst formation rate. These were the 2 main outcomes that were 
compared between the vitrified and HPF fertilised oocytes, alongside recovery rate after 
thawing. Recovery rate, cleavage rate and blastocyst formation rate were chosen based on what 
has previously been described in other oocyte cryopreservation literature (Borini et al., 2008; 
Goldman et al., 2013; Hosseini et al., 2015). Although recovery rate is usually described as 
survival rate (the proportion of oocytes that survive cryopreservation and thawing), recovery 
rate was more appropriate here. This is because survival rate only takes into account the 
proportion of oocytes that were ruptured due to cryopreservation related damage. Recovery 
rate, on the other hand, takes into account the proportion of oocytes that were ruptured due to 
cryopreservation related damage, as well as  the proportion of oocytes that are not able to be 
recovered due to technical issues such as sticking to the carrier they were frozen in or remaining 
stuck in a pipette tip unable to be removed during transfer between wells.  
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2.2 Vitrification and high pressure freezing  
The vitrification, HPF, and thawing protocols were based on a combination of previously 
described methods (Nagy et al., 2017, Hosseini et al., 2015). In order to achieve an optimal 
cooling and warming rate, the solid surface vitrification method was used for this study as 
discussed in section 1.4.  
 
A Leica EM Pact2 High Pressure freezer (Leica microsystems, Vienna, Austria) was used for 
the high pressure freezing of oocytes. A KF80 specimen plunge-freezing device with a metal 
mirror (MM80) attachment (Leica Microsystems, Vienna, Austria) for rapid specimen freezing 
was used to vitrify oocytes. First, the KF80 and high pressure freezing equipment were pre-
cooled. Immature COCs or mature oocytes (MOs) were collected in H199+10%FCS at 38 °C 
and allowed to cool to room temperature. A plastic goblet for storage of cryopreserved oocytes 
was placed in a polystyrene container filled with liquid nitrogen (-196°C). The fibre plug 
sleeves (CryoLogic, Victoria, Australia) were placed in the KF80 for pre-cooling. 
 
In preparation for vitrification and HPF, a 4-well plate was set up with 850 µl of base media, 
equilibration solution, and vitrification solution (Appendix C). The equilibration and 
vitrification media are required to dehydrate the oocyte so that ice crystal formation, which can 
severely damage oocytes, does not occur. The oocytes were dehydrated and shrunk in the 
equilibration media before reaching osmotic balance and recovering their isotonic volume for 
5 to 10 min at room temperature. This was assumed to have occurred if, when observing the 
oocytes under the microscope, the oocyte cytoplasm had shrunk within the zona pellucida and 
then expanded again, as this would indicate that osmotic equilibrium had been reached. The 
oocytes were then further dehydrated in the vitrification solution which has a much higher 
concentration of cryoprotectants for a brief period (25 s) to ensure that a large amount of water 
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is removed from the oocyte before cooling to prevent ice crystal formation. Dimethyl sulfoxide 
(DMSO), ethylene glycol (EG) and sucrose were used as cryoprotective agents for this study, 
as these are widely used in fertility clinics and are considered to be effective. This ensured 
clinical relevance.   
 
To prepare the oocytes for vitrification or HPF, they were transferred into base media 
(H199+20%FCS) at room temperature. Approximately 10-15 oocytes at a time were then 
transferred to equilibration media (BM + 7.5% DMSO + 7.5% EG) to equilibrate for 5-15 min. 
The oocytes were observed during this time to ensure that the perivitelline space has returned 
to normal size after the initial shrinking of the cytoplasm. Any oocytes that did not appear to 
have a normal perivitelline space were left for up to 5 min in the equilibration solution and then 
transferred to the next stage regardless. Next, two oocytes at a time were transferred into 
vitrification solution (BM + 0.5M sucrose + 15% DMSO + 15% EG) for 25 s.  
 
For vitrification, 2 oocytes at a time were frozen in a 2.5 µl droplet on a fibre plug (see Figure 
2-2). The media droplet containing the oocytes on the fibre plug was touched to the surface of 
a copper block in the KF80, vitrifying the oocytes. The fibre plugs were then stored in sleeves 
in plastic goblets that were attached to a cane in a liquid nitrogen dewar.  
 
 
For HPF, 2 oocytes at a time were transferred in 1.5 µl of solution to a gold coated copper 
carrier disc (Leica Microsystems, Vienna, Austria, see Figure 2-2) that was then loaded into 
and frozen using the high pressure freezer. The discs were then placed into cryovials and stored 
in plastic goblets attached to a cane in a liquid nitrogen dewar. Vitrified and HPF oocytes were 
stored in liquid nitrogen for 2 to 10 weeks before thawing.  
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Figure 2-2. Photograph of the fibre plug and sleeve used for vitrification (a) and gold coated 
copper discs used for HPF (b). (c) Schematic showing the dimensions of the HPF discs. Black 
arrows indicate where the sample will be frozen on the carrier.  
 
2.2.1 Oocyte thawing  
As in the freezing protocols, a 4-well plate was set up for thawing. This was prewarmed in the 
CO2 incubator (38.5°C), then transferred to the stereomicroscope warming plate (38.5°C). 
Goblets with fibre plugs and cryo-vials containing the cryopreserved oocytes were collected in 
a flask containing liquid nitrogen.  
 
To thaw the oocytes, fibre plugs containing vitrified oocytes were quickly plunged into 
warming solution 1 for 1 min, and discs containing HPF oocytes were dropped into the well of 
warming solution 1 from approximately 1 cm above to increase the chance that the surface of 
the disc containing the oocyte contacted the liquid first. The oocytes fell from the hook or disc 
into the solution, at which point the hook or disc was removed from the well. A 10 µl pipette 
was then used to transfer oocytes in 1µl of solution to warming solution 2 for 3 min and then 
into base media for 5 min. Finally, oocytes were transferred to BM until there was a pool of 
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oocytes ready for either IVM or IVF. Warming solutions 1 and 2 contained 1M and 0.5M 
sucrose respectively. The oocytes is warmed through decreasing concentrations of sucrose in 
order to remove the cryoprotectants from the oocytes and to avoid osmotic shock (Leibo et al., 
2011).  
 
2.3 Pronuclei staining  
2.3.1 Orcein staining protocol  
An orcein staining protocol previously described (Somfai et al., 2008) was used to stain the 
chromosomes of mature vitrified oocytes. The oocytes were thawed using the method outlined 
in 2.2.1 and transferred into base media at room temperature. In a minimal volume of base 
media, oocytes were transferred onto a glass slide. A coverslip was placed over the oocytes 
with a drop of Vaseline underneath each corner of the coverslip to prevent the oocytes from 
being damaged by the coverslip. Oocytes were then fixed in 1 part acetic acid 3 parts ethanol 
by pipetting the solution under the coverslip. Oocytes were exposed to solution in a humid slide 
staining box for 24 to 72 h after which they were stained with 1% Orcein in 45% acetic acid 
for 20 m. Finally 20% glycerol and 20 % acetic acid in water was added as a differentiation 
step and the coverslips were sealed with nail varnish. Oocytes were imaged by contrast 
microscopy (Olympus BZ15, Tokyo, Japan) to examine the female pronuclei and polar body.  
 
2.3.2 DAPI staining protocol  
4’,6-diamidino-2-phenylindole (DAPI), a fluorescent stain that binds to adenine-thymine rich 
regions of DNA was used to stain for nuclei and sperm heads in fertilised mature oocytes 
(MOs) based on protocols previously described (Oberlender et al., 2016). Due to issues with 
autofluorescence (background staining), a glycine step was added into the original protocol in 
order to bind free aldehyde groups and minimise background staining. Autofluorescence due 
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to free aldehyde groups is a common issue that occurs when using aldehyde fixatives 
(Tokumasu et al., 2003).  
 
After 18 h of co-incubation with sperm, fertilised oocytes were removed from the IVF drops 
and transferred into a 35 mm petri dish containing warm HSOF (38.5°C). Embryos were then 
transferred into 80 µm mesh baskets and taken through the protocol outlined in Table 2-2 
below.  
 
Table 2-2: Protocol for fixation and staining of fertilised oocytes with DAPI.  
Procedure Solution  Time 
Fixed 0.5% Glutaraldehyde in PBS + 0.1% BSA 30 m 
Reduced autofluorescence 0.1% Glycine  60 m  
Wash  PBS + 0.1% BSA  5 m 
Wash  PBS + 0.1% BSA 5 m 
Stain  DAPI 30 m 
Wash  PBS + 0.1% BSA 5 m 
Wash  PBS + 0.1% BSA 5 m 
 
Once the embryos were fixed and stained, they were removed from their baskets and collected 
in an empty petri dish in PBS + 0.1% BSA. The BSA was added to the buffer to prevent the 
oocytes from adhering to the pipette tip. Two embryos at a time were transferred in minimal 
volume of PBS/0.1%BSA onto coverslips with a spacing ring to prevent the oocytes from being 
squashed. Any excess liquid was then removed, and the embryos were covered in 7 µl of 
Prolong Gold antifade reagent with DAPI . 
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The coverslips containing the fertilised oocytes were covered gently with a slide and left to dry 
for 1 min. They were then labelled with the date and freezing method, and placed in the dark 
for 24 h to cure. The fertilised oocytes were observed under a Nikon eclipse t2 inverted 
microscope with Nikon intenslight C-HGFIE fluorescence lamp (Nikon, Tokyo, Japan. 
Excitation l 358nm, emission l 461nm) to check for nuclei and for sperm bound within the 
zona pellucida. Images were taken using a Nikon DS-Qi2 camera in conjunction with Nikon 
NIS-Elements AR imaging software (Nikon). 
 
2.4 Transmission electron microscopy 
The recipes required for TEM staining preparation are outlined in Appendix D. AnalaR grade 
chemicals were used for this experiment from ProSciTech (Thuringowa, Australia) unless 
stated otherwise. In order to examine thawed oocytes under a TEM, oocytes had to first be 
prepared.  
 
Immature COCs that had been frozen using either HPF or vitrification were thawed and 
cultured overnight in IVM media as described in section 2.2.1 and 2.1.2, before they were 
prepared for TEM. After 22-26 h in IVM media, oocytes were transferred into a 35 mm petri 
dish containing room temperature base media. Oocytes were then transferred into baskets with 
80 µm mesh and fixed in 2% glutaraldehyde in 0.1M NaCac + 2mM CaCl2 (pH 7.4) for 1 h at 
room temperature and then overnight at 4 °C. The next day, oocytes in their baskets were 
washed 3 times in 0.1M NaCac for 10 min and 0.1%BSA was added to minimise adhesion. 
Oocytes were transferred in a minimal volume (less than 10µl) of NaCac + 0.1%BSA onto a 
glass slide. Each oocyte was covered with one to two drops of 3% molten low gelling 
temperature agarose (Sigma) in 0.15M NaCac and placed in a refrigerator set at 4°C to set for 
4 min. A razor blade was used to trim the blocks into small (~2 mm) agar blocks. The blocks 
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containing the mature oocytes were then transferred to glass vials containing 2 ml 0.15M 
NaCac. From this point, the oocytes were prepared with their agar block inside the glass vials 
following the protocol outlined in  
Table 2-3. Plastic transfer pipettes with 80 µm mesh copper TEM grids attached to the bottom 
were used to remove solutions from the vials without aspirating the MO agar blocks and new 
solutions were added as per the protocol with new plastic transfer pipettes.  
 
 
Table 2-3. Protocol for preparation of oocytes for TEM 
Procedure Solution Time   
Post-fixed 1% Osmium tetroxide in 0.10M NaCac  1 h 
Washed  0.1M NaCac 3 x 10 min  
Washed  Distilled H2O 2 x 10 min 
Stained  2% Uranyl Acetate in distilled H2O 60 min 
Washed Distilled H2O 10 min  
Dehydrated 50% (v/v) ethanol  10 min  
Dehydrated 70% (v/v) ethanol  15 min 
Dehydrated 95% (v/v) ethanol 15 min  
Dehydrated 100% (v/v) ethanol 2 x 15 min 
Dehydrated Propylene Oxide 2 x 20 min 
Infiltrated 1:1 Epoxy Resin: Propylene  1.5 h 
Infiltrated  2:1 Epoxy Resin: Propylene 2 h 
Infiltrated Epoxy Resin  Overnight  
Embedded Epoxy Resin  
Polymerised  60°C 48 h 
 
Once the oocytes were embedded in polymerised Epoxy resin, a glass knife on a Leica EM 
UC6 ultramicrotome (Leica Microsystems) was used to cut semithin sections containing the 
oocytes. The semithin sections were then mounted on glass slides and stained with 1% 
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methylene blue for 30 s before being rinsed with distilled water. Ultrathin sections containing 
the oocytes were also cut, mounted on formvar coated slot grids, and stained with uranyl acetate 
and lead citrate. 
 
Sections of frozen-thawed oocytes were examined for ultrastructural abnormalities under a 
transmission electron microscope (JEM-2200FS microscope, JEOL, with a F416 camera, 
TVIPS, Tokyo, Japan). Their organelles and ultrastructure were observed using SerialEM 



















A summary of the experimental design for this study can be seen in figure 2-3.  
 
  
Ovaries collected from abattoir COCs aspirated from ovaries  
* 
* 
Objective One: Developmental  
  capacity 
Objective Two: Fertilisation status 
Objective Three: Ultrastructure  
                investigation  
COCs  MOs IVM 
HPF or vitrification  
Thawing 
MOs COCs IVM 
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Figure 2-3. (above) A summary of the experimental design. Abattoir derived oocytes were 
aspirated from sheep ovaries. 297 oocytes were frozen on the day of collection as immature 
COCs and 137 oocytes were matured in vitro for 22-26 h before being frozen as mature oocytes 
(MOs). MOs and COCs were then thawed and COCs were matured in vitro before being 
fertilised to investigate their developmental capacity or fertilisation status or before being fixed 
for TEM to examine their ultrastructure.  
 
2.5 Statistical analysis 
The binomial data regarding number of oocytes that were recovered after thawing, number of 
oocytes that were not recovered after thawing, number of oocytes that cleaved, and number of 
oocytes that did not cleave, were analysed using a generalised linear model with a logit function 




3 Results  
3.1 Developmental capacity after cryopreservation and thawing  
The aim of the IVP work was to compare the developmental capacity of HPF and vitrified 
oocytes after freezing and thawing. This was achieved by fertilising the oocytes in vitro and 
comparing the proportion from each group that cleaved, and developed to the blastocyst stage. 
More than 500 adult ewe ovaries were retrieved from Silver Fern Farm, Finegand meat works 
plant (Balclutha, NZ), yielding over 500 oocytes. A total of 434 oocytes were frozen for this 
project, 164 HPF and 270 vitrified. These were either frozen immediately after aspiration from 
the ovaries on the day of collection, as immature COCs or after being cultured for 22-26  hours 
in IVM as MOs, as was seen in figure 2-3. Ovary collections and oocyte cryopreservation took 
place on 10 separate days between March 13th 2019 and June 24th 2019. Only one collection 
took place in June, the majority of collections were during the mid-late breeding season of 
ewes (in March, April and May 2019). Ovaries were retrieved from all available ewes, 
including several that were pregnant and several with no visible corpus luteum, although the 
majority of oocytes came from ovaries with one or more corpora lutea . Oocytes were aspirated 
from all visible follicles however, only oocytes with more than one complete layer of cumulus 




Figure 3-1. Stereomicroscope image of COCs selected for cryopreservation or IVM after 
aspiration. Each COC is surrounded by one or more layers of compact cumulus cells (cc), and 








A fresh (non-frozen) IVP experiment was performed using oocytes that had been collected, 
transferred straight into IVM media for 22-26 hours and fertilised as MOs without being frozen. 
41 oocytes were collected and fertilised for this experiment. This yielded a cleavage rate of 
95% (39 out of 41) and after 8 days in culture, a 12% blastocyst formation rate was observed 
(5 out of 41).  
A generalised linear statistics model (SPSS) was used to compare the proportion of vitrified 
and HPF oocytes that were recovered after thawing and the proportion of vitrified and HPF 
oocytes that cleaved after IVF. First, an interaction analysis was performed for both sets of data 
(recovery data, and cleavage data) with freezing method as the main predictor and either 
recovery or cleavage as the outcome to test for an interaction between freezing method and 
stage at freezing. No interaction was detected, so the interaction was removed from the model. 
As shown in table 3-1, a lower proportion of HPF oocytes (0.76) were recovered after thawing 
compared to vitrified (0.91) oocytes (P=0.001). Moreover, a lower proportion of HPF oocytes 
(0.09) cleaved after in vitro fertilisation compared to vitrified oocytes (0.41, P<0.001, table 3-
1). The mean proportion of HPF and vitrified oocytes that were recovered and cleaved, with 
95% confidence intervals are shown in Figure 3-2.  
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Table 3-1. Mean proportions of oocytes that were recovered and cleaved after thawing taken 
from the generalised linear model analysis (SPSS). Table shows the effect of freezing method 
and the effect of stage at freezing,  
 Freezing method Stage at freezing 
 HPF Vit  MO COC  
Mean proportion recovered   0.76 0.91*  0.78 0.91* 
 P value           0.001      0.003 
Mean proportion cleaved 0.09 0.41*  0.22 0.19 
 P value  <0.01 0.765 
Note: * indicates a significant difference in mean proportion 
 
 
Figure 3-2. The proportion of oocytes recovered after thawing (a) and oocytes cleaved after in 
vitro fertilisation (b). The middle line indicates the mean and the outer lines indicate the 95% 
confidence interval based on a Wald Chi Square test. A total of 434 oocytes (270 vitrified and 
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164 HPF) were thawed and 121 oocytes (72 vitrified and 49 HPF) were fertilised in vitro for 
these experiments.  
As seen in Table 3-1, the model detected a significant effect of stage at freezing on recovery 
(P=0.003). This indicated that, regardless of freezing method, oocytes that were frozen at the 
immature COC stage were more likely to be recovered than oocytes that were frozen as mature 
oocytes. There was no effect of stage at freezing on cleavage (P=0.765).  A Pearson Chi 
Squared test was performed to determine the ‘goodness of fit’ for the generalised linear model 
that was used. This suggested that the data was under-dispersed and that the P-values 
mentioned can therefore be considered conservative. A summary of the numbers of oocytes 
used for the IVP experiments and the resulting cleavage and blastocyst rates can be seen in 
Table 3-2.  
 
Table 3-2: Recovery rates and cleavage rates of vitrified and HPF mature oocytes and COCs 
after warming and IVF.  
Treatment Stage at Number of  Number of  Number of Number of  
 Freezing oocytes oocytes oocytes  oocytes 
  frozen recovered fertilised (IVF)a cleaved 
 (%)    (%)  
Fresh    41 39 (95)  
Vitrified MO 118 100 (84.7) 14 6 (42.9) 
 COC 152 145 (95.4) 58 23 (39.7) 
HPF MO 19 14 (73.7) 10 1 (10) 
 COC 145 121 (83.4)  39 3 (7.7) 
a This is the number of oocytes that were exposed to sperm by IVF  
Several examples of fresh, vitrified, and HPF oocytes after IVM and after IVF can be seen in 
Figures 3-3 and 3-4 respectively. As is shown in Figure 3-3, not all of the vitrified nor the HPF 
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oocytes were surrounded by expanded cumulus cells after IVM. In fact, a significant proportion 
of the oocytes that were vitrified and HPF appeared to have minimal cumulus cell expansion 
after IVM. Several of these cryopreserved oocytes also appeared to have minimal cumulus 
cells surrounding them after thawing before IVM, suggesting that the cumulus cells had been 
lost during the vitrification and thawing processes, perhaps due to handling. Figure 3-4 shows 
some examples of the embryos that were created using fresh (a), vitrified (b) and HPF (c) 
oocytes. All but one of the fresh in vitro fertilised oocytes appear have developed although, 
several have then arrested before reaching the blastocyst stage. Several of the vitrified oocytes 
have also fertilised, begun to develop and arrested at around the 8- to 12-cell stages. One 
vitrified fertilised oocyte has gone on to form a blastocyst, however, this was the only 
blastocyst that was successfully created using the frozen oocytes. Hence blastocyst formation 
rate was not recorded for this study. A vast majority of the vitrified oocytes shown are 
unfertilised, which is consistent with the low cleavage rate discussed above for HPF oocytes. 





































Figure 3-3. (see above) Stereomicroscope images of (a) fresh, (b) vitrified-thawed, and (c) 
HPF-thawed COCs after 22-26 h of IVM. Oocytes (oo) surrounded by expanded cumulus cells 
(*) can be seen. Several vitrified and HPF COCs are not surrounded by expanded cumulus cells 
(white arrow heads) and these oocytes may have failed to mature. An oi bubble (black arrow) 






























Figure 3-4. (see below) Stereomicroscope images of fresh, vitrified, and HPF embryos after 8 
d in culture. These embryos were created by IVF of (a) fresh (unfrozen) oocytes, (b) vitrified 
oocytes, and (c) HPF oocytes. Expanded blastocysts can be seen as well as embryos that have 
arrested at various stages of development (white arrows) and unfertilised oocytes (black 














































3.2 Fertilisation status after IVF   
3.2.1 Optimisation of nuclei staining technique  
First, previously described Orcein (Prentice-Biensch et al., 2012; Somfai et al., 2008) and 
DAPI (Oberlender et al., 2016) DNA staining protocols were compared to determine which 
protocol was more effective for staining the nuclei in mature ovine oocytes. A large proportion 
of the Orcein-stained oocytes were damaged during the staining and mounting process. 
Moreover, when the Orcein stained oocytes were examined under a compound microscope, it 
was difficult to identify the nuclei amid all of the other structures in the Orcein stained oocytes, 
as can be seen in figure 3-5a.  The DAPI stain was therefore selected for future experiments. 
However, high levels of autofluorescence were observed when using the DAPI protocol and 
this made it difficult to accurately identify the nuclei against the background staining.  
 
A second optimisation experiment was therefore performed staining mature vitrified oocytes 
using a lower concentration of DAPI (1µg/ml as opposed to 2µg/ml) or exposing the oocytes 
to DAPI for a shorter period of time (15 min as opposed to 30 min). Although this ameliorated 
the problem to some degree, autofluorescence from the free aldehydes in the glutaraldehyde 
fixed oocytes was still high, making it difficult to accurately identify the nuclei against the 
background staining. Therefore, an extra step treating the oocytes with 0.1% glycine after 
glutaraldehyde fixation was added to bind the free aldehyde groups and reduce 
autofluorescence. This reduced autofluorescence significantly and the final two groups of 
oocytes were thawed, fertilised, and stained using the DAPI with an additional glycine step 
added, as described in section 2.3. An example of a vitrified-warmed oocyte that has been in 
vitro fertilised and stained using this optimised protocol can be seen in figure 3-5b. The nuclei 
and sperm heads can be clearly distinguished. Two optimisation experiments and 3 

















Figure 3-5. Compound light microscope images of vitrified-thawed in vitro fertilised COCs 
after 18 h of coincubation with sperm stained with (a) Orcein and (b) DAPI (with a fluorescence 
lamp, excitation l 358nm, emission l 461nm). The oocyte (oo) and surrounding zona pellucida 
(zp) can be seen. In the Orcein treated oocyte (b), no further structures can be identified and it 
is not clear whether there are sperm bound within the zona pellucida or not. One structure can 
be seen which could possibly be the maternal pronuclei (white arrow, ?), however, it was not 
possible to be certain about this and similar structures were not apparent in the other Orcein 
stained mature vitrified oocytes that were examined. However, in the DAPI stained vitrified 
oocyte (b) the male and female pronuclei can be seen (white arrows) adjacent to one another 
as well as sperm bound within the zona pellucida (*). It is also possible to make out the 
perivitelline space (pv) in the DAPI stained oocytes. This helps to determine whether there are 
sperm bound within the zona pellucida more accurately and to see the polar body when it is in 
focus.  
 
3.2.2 Fertilisation status of Vitrified and HPF oocytes  
In order to determine whether the zona reaction had occurred prematurely and whether it had 
successfully blocked polyspermy or not, 36 vitrified and 40  HPF COCs were thawed and 
underwent IVM, IVF, and staining using the optimised DAPI and glycine protocol to count the 
nuclei present in the oolemma and the sperm present within the zona pellucida 18 h after IVF. 
During thawing, fertilisation and fixation, there was notable loss of oocytes due to technical 
challenges such as failure to recover after thawing, oocytes adhering to the pipette tip or mesh 
basket, or rupturing during oocyte handling. Therefore, only 8 HPF and 19 vitrified fertilised 
oocytes were examined. The percentage of these that were found to have zero, one, two, or 
three visible nuclei are shown in Figure 3-6.  None of the oocytes that were examined had more 




Figure 3-6. Percentage of vitrified and HPF fertilised oocytes with 0, 1, 2, or 3 visible nuclei 
after DAPI staining. Blue columns represent the vitrified oocytes and orange columns represent 
the HPF oocytes.  
 
All of the vitrified and HPF oocytes that were examined were found to have sperm bound 
within their zona pellucida. This suggests that the zona reaction had occurred successfully, 
preventing polyspermy.  5 out of 27 of the fertilised oocytes (19%) had only 0 to 1 visible 
nuclei which suggests that they were not fertilised. This could suggest that the zona reaction 
has occurred prematurely, blocking fertilisation as all of the oocytes had sperm bound within 
the zona. The presence of only 1 nuclei in the ooplasm could also indicate that the oocyte has 
not matured successfully during IVM, in which case the first meiotic division would not have 
taken place, leading to an absence of the first polar body. These numbers are consistent with 
the low cleavage rates reported above in section 3.1  which are indicative of low fertilsation 



















brightfield (d) that show various examples of what the nuclei that were counted  in this study 




Figure 3-7. (above) Compound fluorescence (excitation l 358nm, emission l 461nm) 
microscope image examples of DAPI stained vitrified-thawed (a and c), and HPF-thawed (b 
and d) in vitro fertilised oocytes after 18 h of coincubation with sperm. The presence or absence 
of sperm heads (*) bound within the zona pellucida was recorded under fluorescence (a, b, and 
c) and brightfield (d) and the number of nuclei visible under fluorescence (maternal pronuclei, 











3.3 Ultrastructural investigation under TEM  
In order to compare the ultrastructural changes that occur in immature and mature oocytes 
frozen using vitrification and HPF, 5 vitrified COCs, 3 HPF COCs, 2 vitrified mature oocytes, 
and 3 HPF mature oocytes were thawed for ultrastructural investigation and the COCs were 
matured in vitro. Mature oocytes were then fixed, embedded in resin and sectioned for 
examination under the transmission electron microscope as described in section 2.4 to compare 
their ultrastructure after freezing and warming.  
 
Figures 3-8 and 3-9 show examples of the zona pellucida and outer ooplasm of in vitro matured 
oocytes that were frozen at the immature and mature stage respectively. Regardless of which 
stage they were frozen at, or which freezing method was used, all of the oocytes that were 
examined for this study showed no evidence of the abundance of cortical granules that are seen 
immediately under the ooplasm of fresh-fixed mature oocytes. Moreover, all of the oocytes 
examined showed some degree of vesicle and lipid enlargement and coalescence of lipids 
which is a sign of ultrastructural damage caused by the cryopreservation process. An example 
of this is shown in Figure 3-10 which shows the central ooplasm of a mature oocyte that was 
HPF at the COC. Extensive coalescence of vesicles can be seen and there is also evidence of 
vesicle degradation. There was also some evidence in the various oocytes of irregular organelle 
distribution. For example, the vitrified oocyte in Figure 3-8a appears to have mitochondria 
clustered throughout the ooplasm, which is usually what is seen in immature COCs but would 
not be expected in a mature oocyte. Moreover, the organelles in the vitrified oocyte in Figure 
3-11 are clustered in the centre of the ooplasm and appear to have failed to redistribute after 
the cytoplasmic shrinkage that occurs during the vitrification and HPF process when the 
oocytes are exposed to high concentrations of cryoprotectant. There is also evidence of 
degradation of these organelles and minima lipids can be seen in this oocyte.  
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Two out of five of the oocytes that were vitrified as COCs were degenerated, as seen in Figure 
3-11. This degeneration likely occurred prior to freezing, as the cumulus cells surrounding 
these oocytes show no evidence of degeneration and appear to have good ultrastructure, 
suggesting the degeneration was not a result of the cryopreservation or the fixation process. 



















Figure 3-8. (above) Transmission electron micrographs of the zona pellucida (zp) and outer 
ooplasm of oocytes frozen as mature oocytes, thawed, fixed, and sectioned. No obvious 
differences can be seen between the (a) vitrified oocyte and (b) HPF oocyte. Vesicles (V), 
lipids (L), cortical granules (black arrow heads) and mitochondria (black arrows) can be seen. 
Unlike in fresh-fixed mature oocytes, both the vitrified and HPF oocytes in this figure have 
very few cortical granules present at the oolemma. The vitrified oocyte (a) also appears to have 
its mitochondria clustered throughout the ooplasm, as would usually be expected of an 
immature COC but is not normally seen in mature oocytes. It would normally be expected that 
a mature oocyte would have mitochondria evenly distributed throughout the ooplasm. Scale 




Figure 3-9.(below) Transmission electron micrographs of the zona pellucida (zp) and outer 
ooplasm of oocytes frozen as COCs, thawed, matured in vitro, fixed and sectioned.  There are 
no apparent differences between the (a) vitrified oocyte and (b) HPF oocyte. Vesicles (V), 
lipids (L), cortical granules (black arrow heads) and mitochondria (black arrows) can be seen. 
Unlike in fresh-fixed mature oocytes, both the vitrified and HPF oocytes in this figure have 
very few cortical granules present at the oolemma. The HPF oocyte (b) also appears to have a 






































Figure 3-10 (above) Transmission electron micrograph of the central ooplasm of mature HPF 
oocyte that was frozen as a COC, thawed, matured in vitro, fixed and sectioned. Scale bar 5 
µm. There is evidence of enlarged and coalesced vesicles (V) and enlargement of lipids (L) in 
(a). There is also some evidence of mitochondria clustering and degradation of vesicles  (b). 
Staining artefacts are visible (black arrows) and these are due to knife cuts and folds in the 


















Figure 3-11. (below) Transmission electron micrograms of a mature vitrified oocyte and 
surrounding cumulus cells (white arrows). that were frozen as a COC. There is evidence (a) 
that the organelles in the cytoplasm have not redistributed after the cytoplasmic shrinkage that 
occurs in the vitrification process due to the cryoprotectants. The black outline encloses the 
organelles which are seen to be clustered in the centre of the oocyte. Evidence of cytoplasmic 
degeneration (black arrows) can also be seen in (b). The cumulus cells (white arrows) appear 
to have maintained a normal ultrastructure as their cytoplasm is smooth and this indicates that 
the oocyte degeneration has occurred before the oocyte was frozen and is not a result of the 
freezing or fixation processes.  









4.1 Sheep as a model for human assisted reproduction research  
Sheep oocytes have been used as model systems for previous oocyte cryopreservation studies. 
This is because previous research has demonstrated significant likeness between human and 
sheep oocytes and early embryos. The timing and neuroendocrine control of embryo metabolic 
activity and early embryonic development are similar in sheep and humans (Loi et al., 2011). 
Oocyte size, oogenesis and folliculogenesis have also been shown to be similar in sheep and 
humans, as has the structure of the ovarian follicle (Barry et al., 2008; Loi et al., 2011; 
McMillen, 2001). Moreover, it is feasible to obtain abattoir derived sheep oocytes to use for 
research without the need to breed or euthanase animals for the purpose of the research. This 
addresses ethical issues and avoids the use of human gametes or the creation of human embryos 
for research. Finally, ovine in vitro embryo production and in vitro embryo culture protocols 
are well-established and are similar to human protocols (Hosseini et al., 2015; Reader et al., 
2015).  
 
In sheep, the presence of one or more corpora lutea on the follicle is evidence that the sheep 
has ovulated and is therefore in oestrus. Sheep are seasonal breeders and sheep in vitro embryo 
production (IVP) is more successful when performed during the natural breeding season of the 
animals (Reader et al., 2015). For most breeds of sheep, this is during Autumn. Oocyte quality 
has been shown to be poorer outside of this breeding season, when the animals are in anoestrus 
(not cycling). Therefore, sheep oocytes were collected for this study in Autumn in order to 
ensure that the oocytes were of high quality and to optimise the chances of successful IVP.  
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4.2 Developmental capacity  
4.2.1 IVP culture system 
An IVP experiment using fresh (non-frozen) oocytes was performed as a control, to confirm 
that the previously established IVP culture system used was working in our laboratory. IVP 
had not been performed in our laboratory previously. This yielded a cleavage rate of 95% and 
a blastocyst formation rate of 12%. This cleavage rate was higher than what has been reported 
previously, as is shown below. However, the blastocyst formation rate was significantly lower 
than what was expected based on other studies performing IVF on fresh adult sheep in vitro 
matured oocytes. Hosseini and colleagues showed a cleavage rate of 86.5% and a blastocyst 
formation rate of 38.4% (Hosseini et al., 2016). Similarly, Reader and colleagues demonstrated 
a 73.38% cleavage rate and a blastocyst formation rate of 29.2% (Reader et al., 2015).   
 
Successful embryo culture relies upon creating a culture environment that is analogous to the 
sheep uterine environment in which oocytes are fertilised and develop in vivo. Oocytes and 
developing embryos are sensitive to temperature changes, osmotic changes, and pH changes 
(Kane, 2003).  The low blastocyst formation rates recorded in my study could be partially due 
to suboptimal lab conditions. For example, when the culture dishes were removed to observe 
the embryos and developing embryos during this study, they were exposed to excess light and 
air. There is evidence that exposure to light and room temperature can hinder successful 
embryo development as well as cause changes to the media pH which further decrease the 
chances of successful embryo development to the blastocyst stage (Kane, 2003).  
 
For future embryo culture work, it would be beneficial to minimise exposure to the lab 
environment, room temperature, and light. Ideally, an embryoscope incubator with a time lapse 
camera would prevent the need to remove the embryos from their incubator to observe their 
 62 
development and would avoid exposing them to uncontrolled lab environment after they were 
placed in culture, increasing the chance that the oocytes would be fertilised successfully and 
the resulting embryos would develop to the blastocyst stage.  
 
Although a 12% blastocyst formation rate is not optimal, the fresh IVP experiment did 
demonstrate that using the previously established IVP protocols and culture system, it was 
possible to successfully fertilise sheep oocytes and that a proportion of these fertilised oocytes 
were able to develop to the blastocyst stage under these conditions in our lab. Improving the 
development rate to achieve a blastocyst formation rate of at least 30% would mean that fewer 
oocytes were required to study oocyte cryopreservation and oocyte quality. Although this 
would be advantageous, as there is a lot that is not known about oocyte quality and the effect 
of oocyte cryopreservation on oocyte ultrastructure and developmental capacity, the vitrified 
and HPF oocytes were both subjected to the same lab conditions during this study. Therefore 
an improvement in the development rates would not be expected to affect the differences 
between vitrified and HPF oocytes that were observed during this study.  
 
The aim of the IVP work in this study was to compare the developmental capacity of HPF 
oocytes with that of vitrified oocytes. This was achieved by performing IVP on HPF and 
vitrified oocytes and comparing the proportion of each group that were able to be recovered 
after thawing, and the proportion of each that were able to cleave after in vitro fertilisation, as 
a measure of their capacity to support fertilisation. 
 
4.2.2 Fewer HPF oocytes were recovered after thawing than vitrified oocytes  
Fewer HPF oocytes were recovered after thawing, compared to vitrified oocytes. With the 
exception of the recovery rate for mature oocytes that were cryopreserved using HPF, these 
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recovery rates are within the range of what other studies using similar methods have reported 
for vitrified oocytes (Goldman et al., 2013; Hosseini et al., 2015; Nagy et al., 2009).  
 
The lower recovery rate recorded for HPF oocytes may be due to the warming rate. There is 
evidence in the literature to suggest that a rapid warming rate is critical for oocyte survival and 
to prevent ice crystal formation after cryopreservation (Ledda et al., 2006; Leibo et al., 2011). 
For this study, however, HPF oocytes were frozen on gold-coated copper discs shown in 
section 2.2. These copper discs may not have allowed HPF oocytes to be warmed as rapidly as 
the fibre plugs that were used for vitrification. The discs are relatively thick and tended to float 
on top of the warming solution for several seconds before they were submerged. Moreover, 
often the flat surface of the disc that did not contain the oocyte would contact with the warming 
solution before the surface that contained the oocyte did, causing a delay in the oocyte coming 
into contact with the warming solution. Slow warming rate can lead to severe ice crystal 
damage causing oocytes to rupture as they are warmed, preventing them from being recovered 
(Leibo et al., 2011). If it were possible to increase the rate of warming for HPF oocytes after 
freezing, they may be more likely to survive and be recovered after thawing.  
 
For future work it would therefore be beneficial to freeze HPF oocytes on an apparatus that 
would allow more rapid warming of the oocytes. A specimen tube system (Leica 
Microsystems) where the oocyte is frozen in a thin cellulose microcapillary tube and placed 
inside of a thin copper tube could allow the oocytes to be warmed rapidly and help to 
circumvent these issues, increasing the chances of survival and successful development to the 
blastocyst stage. The microcapillary tube can be removed from within the copper tube before 
warming, and has an internal diameter of 200 µm  (Hohenberg et al., 1994).  
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4.2.3 Fewer HPF oocytes cleaved than Vit oocytes  
Contrary to the hypothesis, this study showed that fewer HPF-thawed oocytes cleaved after 
IVF compared to vitrified oocytes. These cleavage rates were considerably lower than those 
reported in similar studies using vitrified human and bovine oocytes (Borini et al., 2004; 
Kuwayama et al., 2005; Yoon et al., 2003). However, there is large variation in reported 
cleavage rates and a cleavage rate of only 18% was previously reported using vitrified sheep 
oocytes (Hosseini et al., 2015).  
 
Oocyte developmental capacity after vitrification has also been shown to be affected 
significantly by ice crystal damage occurring due to a suboptimal warming rate (Ledda et al., 
2006; Leibo et al., 2011). The low cleavage rates recorded after HPF could therefore have been 
affected by a reduced warming rate as described above. The ice crystal formation is not always 
severe enough to cause the cell to rupture however, even minor ice crystal related damage can 
reduce the oocyte’s developmental capacity. It is possible that increasing the rate of warming 
using the microcapillary specimen tube as described above could also increase the HPF 
oocyte’s developmental capacity and increase the chances of cleavage and development to the 
morula and blastocyst stages.  
 
During this study, only one single vitrified oocyte was able to support development to the 
blastocyst stage after IVF and no HPF fertilised oocytes were able to develop to the blastocyst 
stage. This suggests that both vitrified and HPF oocytes were unable to support successful 
fertilisation and normal embryonic development, indicating that they are of poor quality. Signs 
of ice crystal related damage were seen in the TEM images discussed in section 3.3 which 
could explain the poor developmental capacity of these oocytes. The ultrastructural changes 
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that were seen and the affect they may have on oocyte developmental capacity are discussed 
below. Another cause of this poor developmental capacity could be inefficiency of IVM.  
 
It is widely accepted that IVM is inefficient compared to in vivo maturation achieved through 
controlled hormone stimulation (Brambillasca et al., 2013; Wininger et al., 2002). (Chian et 
al., 2017) reported an in vitro maturation rate of 70.4% for fresh immature human COCs which 
was significantly (P < 0.05) greater than the 50% maturation rate that was achieved for human 
oocytes that had been vitrified as COCs. Although, IVM is more successful in sheep and other 
animal models than humans, successful IVM relies on vital signals from the cumulus cells and 
cumulus cell expansion (Robker et al., 2018). During this experiment, a significant proportion 
of vitrified and HPF cells did not appear to have expanded cumulus cells after IVM, suggesting 
that they had failed to mature. This could have been due to a failure to maintain the cumulus 
cells during the freezing and thawing processes as several of the immature COCs that were 
vitrified and frozen appeared to have very few remaining cumulus cells after thawing. In this 
case, the absence of cumulus cell expansion may have simply been due to a lack of cumulus 
cells to start with, which could reduce the capacity of the oocytes to mature successfully during 
IVM. There is evidence, however, to suggest that during vitrification the gap junctions through 
which cumulus cells and oocytes communicate to orchestrate maturation are disrupted 
(Brambillasca et al., 2013). This could suggest that the failure of cumulus cells to expand was 
due to failure of the oocyte to mature because of the disruption of communication between the 
oocyte and its cumulus cells even if the cumulus cells were still intact. Oocytes have not been 
cryopreserved using HPF before, so further research is required to confirm whether HPF also 
disrupts oocyte-cumulus cell gap junctions. However, as the HPF oocytes also showed signs 
of cumulus expansion failure during this study it seems likely that this is in fact the case.   
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Observing cumulus cell expansion can be beneficial to estimate IVM efficiency. However, in 
order to accurately assess the efficiency of IVM, the oocytes must be observed under a light 
microscope or a compound microscope to determine whether a polar body is present in the 
perivitelline space. This would indicate that maturation has successfully occurred. If no polar 
body was observed, then the oocyte could not have successfully matured to the metaphase two 
stage and it can be assumed that IVM was unsuccessful. In order to quantify this, the proportion 
of oocytes that did and did not successfully develop to the mature Mll phase with a visible 
polar body could be measured.  
 
4.2.4 Developmental capacity of mature and immature oocytes  
Interestingly, a significant effect of oocyte maturation stage at freezing was detected for 
recovery rate. This indicated that a significantly lower proportion of mature oocytes were 
recovered after cryopreservation and thawing compared to immature COCs that had been 
frozen, regardless of which method was used. This finding was surprising because there is 
substantial evidence that the cryopreservation of mature oocytes is more successful than that 
of immature COCs (Borini et al., 2010; Brambillasca et al., 2013; Chian et al., 2017). However, 
the lower proportion of mature oocytes that were recovered after thawing could be reflect the 
technical challenges that come with freezing and thawing mature oocytes, rather than 
cryopreservation related damage. The expanded cumulus mass of mature oocytes are quite 
sticky due to cumulus cell secretions and this can cause the oocytes to adhere to the pipette tip 
or freezing apparatus, preventing them from being recovered and increasing the chance that 
they are damaged due to handling.  
 
No significant effect of stage at freezing was detected for cleavage rates, indicating that there 
was no difference in the developmental capacity of oocytes that were cryopreserved at the 
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mature or immature stage. This finding was unexpected because, as mentioned above, we 
would expect mature oocytes to retain a higher developmental capacity after freezing than 
immature oocytes. This has been attributed to several phenomena. For example, one study has 
reported that the membrane of immature COCs has a different composition to that of mature 
oocytes. This study found that immature COCs therefore have reduced resilience to ice crystal 
formation and low temperatures compared with mature oocytes whose membranes are better 
equipped to tolerate these temperatures (Brambillasca et al., 2013). Ultimately, however, the 
key limitation to freezing immature COCs seems to be the inability to maintain communication 
between the oocyte and its cumulus cells (Chian et al., 2017) When oocytes are frozen at the 
mature stage, they are no longer dependent on communication from the cumulus cells to 
mature, hence cryopreservation of mature oocytes is more efficient. Mature oocytes only need 
their cumulus cells to produce hyaluronic acid to stimulate the acrosome reaction and this 
doesn’t require communication between the oocyte and the cumulus cells hence fertilisation 
can still be successful even when cumulus cell oocyte communication is disrupted. Because of 
the reported loss of oocyte-cumulus communication after cryopreservation, and the necessity 
of removing the cumulus cells of COCs before vitrification in some instances due to size 
limitations, we would expect oocytes frozen at the mature stage to yield a higher cleavage rate 
than oocytes frozen as immature COCs. It is important to note that only 24 oocytes that were 
frozen as mature oocytes were fertilised for the IVP experiments in this study, and 97 COCs, 
so it is possible that this study did not have large enough numbers of mature oocytes in the IVP 




4.3 Fertilisation status  
The fertilisation status investigation was designed to investigate and compare the fertilisation 
status of mature vitrified and HPF oocytes after IVF, with the particular objective of 
determining whether polyspermy was occurring in either group, and whether the zona reaction 
had occurred before or after sperm penetration.  
 
There is evidence in the literature to suggest that during the vitrification of mature oocytes, 
cooling related damage can cause the cortical granules to exocytose and release their contents 
prematurely (Gook et al., 1994). This leads to zona hardening and prevents vitrified-thawed 
oocytes from being able to be fertilised normally using IVF. Because of this, vitrified-thawed 
oocytes are generally fertilised by ICSI (Polak de Fried et al., 1998; Porcu et al., 1997) . 
Contrary to this, several studies have reported successful fertilisation and early embryonic 
development of vitrified-warmed oocytes after IVF (Gómez et al., 1998; Hosseini et al., 2015). 
This latter finding is consistent with the current study. A proportion of vitrified oocytes (0.41) 
did successfully cleave after IVF during my IVP experiments, which could suggest they had 
been successfully fertilised. Moreover, when the fertilsation status of mature vitrified thawed 
oocytes was investigated after 18 h of coincubation with sperm, several oocytes contained both 
a male and a female pronuclei, confirming that successfully fertilisation of vitrified oocytes 
was occurring. The results from the DAPI staining experiments also indicated that polyspermy 
did not occur in these oocytes and that the poor development observed in experiment one is not 
likely to be due to polyspermy.  
 
The presence of male and female pronuclei in the oolemma of vitrified and HPF oocytes, as 
well as the absence of any extra nuclei and the presence of sperm bound within the zona 
pellucida, all indicate that the zona reaction is occurring successfully mature oocytes frozen by 
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either vitrification or HPF. This conclusion can be drawn because, if the zona reaction was 
occurring prematurely during the freezing process and causing zona hardening then one would 
not expect sperm to be able to penetrate the zona pellucida. Hence there would not be male 
pronuclei visible in these oocytes. Furthermore, if the zona reaction was not occurring at all 
then one would not expect to see sperm bound within the zona pellucida as these sperm would 
be able to penetrate and one would therefore expect to see multiple nuclei or condensed sperm 
heads present within the oolemma indicating that polyspermy was occurring. Therefore the 
results of the fertilisation status investigation experiments suggest that fertilisation of vitrified 
oocytes through IVF rather than ICSI is in fact possible, although is possibly inefficient.  
 
A limitation of  the fertilisation investigation experimental design is that the oocytes were fixed 
in order to stain them and count the nuclei, so it was not possible to follow these oocytes 
through and determine their developmental capacity, and in particular, whether or not they 
would have cleaved. For future work it would be advantageous to use a live cell imaging system 
with a non-toxic stain, such as Hoechst (Liu et al., 2000) to visualise the nuclei and assess 
fertilisation status then continue to observe their early development. This would provide 
valuable information because there is some evidence in the literature to suggest that when 
oocytes are left for two or more hours after warming to recover, they can undergo ageing and 
spontaneous resumption of meiosis or even parthenogenetic activation (Asgari et al., 2011). 
Due to the technical difficulty of oocyte thawing after vitrification and HPF and the large 
number of oocytes that I was dealing with at one time, there was often a delay of up to 2.5 h 
between commencing thawing and beginning IVM or IVF. This could mean that a proportion 
of the cleavage and early embryonic development I reported in my IVP experiments was not 
necessarily due to successful fertilisation, but was simply a result of parthenogenetic activation. 
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Arav and colleagues reported successfully embryonic development of parthenogenetically 
activated sheep oocytes up to the 8-cell stage (Arav et al., 2005).  
 
Some challenges in counting the nuclei were encountered during this investigation whereby it 
was sometimes difficult to tell where within the oocyte and its zona pellucida the stained 
structures (nuclei and sperm heads) were. This was exacerbated by the fact that the compound 
microscope and the depth of the oocyte and mounting medium would not allow me to focus 
through the entire oocyte. Due to this, male and female pronuclei and female polar bodies were 
counted all together as ‘nuclei’ as it was not always possible to differentiate between them. 
Similar studies have been done in the past where the zona pellucida was removed before the 
nuclei were counted to avoid mistakenly counting a polar body or sperm heads that were 
trapped in the zona. This method could be useful for future work, however, this would not 
allow me to view the sperm in the zona pellucida so it would be difficult to determine whether 
the zona reaction has occurred prematurely or not. Alternatively, for future work it could be 
beneficial to use a confocal microscope rather than a compound one to take serial sections of 
the fertilised oocytes and build a much more accurate 3D picture of where within the oocyte 
the nuclei and sperm heads are located.  
 
4.4 Ultrastructural investigation 
Out of the five oocytes that were vitrified as COCs, two were degenerated. Although the 
oocytes were degenerated, the surrounding cumulus cells appeared to have good ultrastructure 
and showed no sign of degeneration. This suggests that the degeneration is unlikely to have 
been caused by the vitrification or fixation steps and had likely occurred before the COCs were 
frozen. There was a delay of up to 5 h between slaughter of sheep and collection of ovaries, 
and completing cryopreservation of the resulting oocytes, as mentioned in section 2.1 which 
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may have caused this degeneration. Although oocytes in their follicles are able to survive for 
several hours after slaughter, there is evidence that some oocytes do eventually begin to age 
and degenerate (Zhang et al., 2014). It is likely that the oocytes that were affected by 
degeneration were amongst the last oocytes to be cryopreserved on the day of collection and 
had therefore experienced the longest delay in freezing after collection, leading them to 
degenerate. It was interesting to note that when examining those same oocytes under a 
compound microscope before fixation, their degeneration was not apparent. This highlights 
one of the problems for assisted reproduction using cryopreserved oocytes; it is not possible to 
observe the extent of the damage of cryopreservation to the live oocytes under light microscope 
before fertilising them.  
 
The aim of the ultrastructural investigation was to compare the effects of vitrification and HPF 
on mature oocytes that had been frozen before and after IVM. However, owing to the low 
numbers of oocytes that were examined for this study due to time constraints, and the 
heterogenous nature of mature oocytes, no comparison could be made between the vitrified 
and HPF oocytes. Several interesting conclusions could be drawn, however, by comparing the 
ultrastructure of the cryopreserved oocytes that were examined to the fresh-fixed oocytes 
shown in Figures 1-2 and 1-3 in section 1.3 and to what has been previously reported about the 
ultrastructure of mature oocytes.  
 
Regardless of which freezing method was used and which stage the oocytes were frozen at, all 
of the oocytes that were examined under a transmission electron microscope had very few 
cortical granules present and did not have an abundance of cortical granules lined up 
underneath the oolemma as is expected in a mature oocyte (Hosseini et al., 2016). However, 
due to time constraints, only very small numbers of oocytes were observed under TEM.  This 
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absence of cortical granules likely suggests that they have in fact been prematurely released or 
degraded. Interestingly, none of the frozen-thawed-fertilised oocytes described in section 3.2.2 
of this study were affected by ‘zona hardening’ and all seemed to have had a successful zona 
reaction. This is contrary to what is expected based on the literature. One hypothesis that could 
explain this observation is that the cortical granules were degraded rather than released 
prematurely, meaning that the zona reaction was not occurring prematurely, and an abundance 
of cortical granules is not required for the zona reaction as is previously postulated. It is 
possible that the presence of several cortical granules is sufficient to drive the zona reaction. 
Further study is required to understand what is happening to the cortical granules and the zona 
pellucida during cryopreservation to determine why we are seeing an absence of cortical 
granules underneath the oolemma of mature oocytes and whether this observation is in fact 
preventing the zona reaction from occurring as is previously postulated. This could be achieved 
by using a cortical granule specific fluorescent marker and a live cell imaging system to observe 
in vivo matured oocytes, in vitro matured oocytes and oocytes that have been cryopreserved 
before and after maturation.  
 
One study has shown that the developmental capacity of vitrified-warmed mature oocytes is 
impacted to a larger extent by cytoplasmic damage than by nuclear damage (Hosseini et al., 
2016). This suggests that the cytoplasmic ultrastructure is affected by oocyte vitrification, 
which is consistent with what was observed under transmission electron microscopy in this 
study. As outlined in section 3.3, this study showed some evidence of cytoplasmic and 
organelle damage after cryopreservation and warming which could account for the reduced 
developmental capacity that we are seeing in cryopreserved oocytes. This is consistent with the 
literature available on mature oocytes (Hosseini et al., 2015; Hosseini et al., 2016; Noyes et al., 
2010), although minimal research has been done looking into the effect of vitrification on 
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immature oocytes, and there is no previous study investigating the effect of HPF on mature or 
immature oocytes.  
 
In this study, cryopreserved oocytes were found to have swollen or enlarged vesicles and lipids, 
with evidence of vesicle coalescing. Although this has been linked to poor developmental 
capacity, not a lot is known about how the changes reported in this study and in Hosseini’s 
work actually affect developmental capacity at the biological level. This is because there is 
limited knowledge available about the role of oocyte organelles in fertilisation and early 
embryonic development. Studies have shown the importance of mitochondria for early 
development, the zona pellucida for fertilisation and the cortical granules to block polyspermy 
but beyond this the role of other organelles such as lipids and vesicles is not well understood. 
Moreover, very few investigations have been performed to determine the ultrastructure of a 
frozen-thawed oocyte. Further research is required in this field and TEM is a powerful tool that 
can be used to get a close-up look at cryopreserved and fresh oocytes and their organelles. 
  
4.5 Conclusions and future directions 
Contrary to the hypothesis of this thesis, it can be concluded that, when mature and immature 
oocytes are HPF on gold coated copper discs, HPF does not improve oocyte cryopreservation. 
HPF oocytes have reduced developmental capacity compared with vitrified as they have a 
reduced capacity to support fertilisation and early embryonic development. Further research is 
required to determine whether this reduced developmental capacity is due to warming rates. 
Further research is also required to compare the ultrastructural preservation of vitrified and 
HPF oocytes after cryopreservation, as this study was the first to observe HPF-thawed oocyte 
ultrastructure and did not have sufficient numbers to make a comparison between the vitrified 
and HPF oocytes. In the future it would therefore be advantageous to repeat the experiments 
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described in this thesis using the microcapillary specimen tube system described in section 
4.2.2 for HPF and with larger numbers.  
 
For future TEM ultrastructural investigations, it would be beneficial to have a selection process 
that would allow the imaging of only good quality oocytes that are not degenerated and have 
matured successfully before cryopreservation, fixation and imaging.  This would give the 
clearest picture about the effects of vitrification and HPF on oocyte ultrastructure. Although 
very little is known about what makes a good quality oocyte, one way that this could be 
achieved is to separate the oocytes with expanded cumulus cells after IVM from those without 
expanded cumulus cells and to observe them separately.  
 
As IVM in both humans and sheep is inefficient, particularly when performed after 
cryopreservation, it would also be interesting to repeat these experiments using sheep oocytes 
that were matured in vivo in order to compare the developmental capacity and ultrastructural 
changes of in vivo matured vitrified and HPF oocytes.  
 
Regardless of whether HPF is pursued as a potential oocyte cryopreservation method or not, 
there is a pressing need to improve oocyte cryopreservation to increase the cleavage rates, 
blastocyst formation rates, implantation rates, pregnancy rates, and live birth rates achieved 
using cryopreserved oocytes as well as to develop an efficient method to cryopreserve 
immature oocytes and meet the needs of the women for whom ovarian stimulation treatment is 
contraindicated. One way that this will be achieved is through improving IVM. Further 
ultrastructural studies to broaden our understanding of oocyte biology could also help to 
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Appendix A: Sheep IVP media recipes  
M199  
1 sachet M199 powder (Sigma M5017 or Gibco 31100-035)  
500 ml H2O 
63.35 mg Kanamycin (Sigma K1277-5G)  
 
Stock B  
1.05 g NaHCO3 (Sigma S5761-500G) 
50 ml H2O final volume 
 
 
Stock C  
18 mg Pyruvic Acid (Sigma P4562-5G) 
5 ml H2O final volume 
 
Stock H  
1.5 g Hepes Free Acid (Sigma H6147-25G) 
1.625 g Hepes Sodium Salt (Sigma H3784-25G) 
50 ml H2O final volume 
 
BSA (20%) 
4.0 g BSA (ICPbio low endotoxin ABRE) 
20 ml 0.9% Saline  
 
B199 (100 ml) 
50 ml 2 x M199 
10 ml Stock B  
0.6 ml Stock C  
39.4 ml Milli Q H2O 
 
 
H199 (200 ml) 
100 ml 2 x M199  
12 ml Stock H  
4 ml Stock B  
84 ml MilliQ H2O 
 
Aspiration media (H199 + herapin + BSA) 
48.9 ml H199  
93 µl Herapin (5000 iu/ml)  
1 ml BSA (20%)  
 
H199 + 10% FCS 
18 ml H199  
2 ml FCS  
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B199 + 10% FCS  
9 ml B199  
1 ml FCS  
 
Cysteamine  
10 mg Cysteamine (Sigma M6500-25G) 
Mls = wt divided by 1.136 B199 + 10%FCS  
 
Hypotaurine  
2 mg Hypotaurine 
mls = wt divided by 0.218 0.9% saline  
 
Penacillamine 
5 mg Penicillamine (Sigma P4875-1G)  
mls = wt divided by 0.5968 0.9% saline  
 
Day 1.5 Post Oestrus Sheep Serum  
Transfer blood to 250 ml centrifuge bottles and allow to clot overnight at 4°C 
Centrifuge at 3000 rpm for 15 m  
Sterile filter 0.2 µm vacuum filter 
Transfer to 50 ml falcon tubes  
Heat inactivate in 56°C water bath for 30 m  
 
Maturation media  
1 ml maturation media (Ruakura)  
10 µl cysteamine  
 
IVF media  
8 ml IVF media (Ruakura)  
100 µl Penicillamine/Hypotaurine stock  
2 ml Sheep serum (day 1.5 post oestrus)  
 
Mineral Oil: Sigma M5310-1L Embryo culture tested, sterile filtered 
Media from AgResearch, Ruakura, NZ.  
 
Appendix B: Bovipure gradient preparation to separate motile sperm 
 
 
Table 0-1: Bovipure gradient preparation to separate motile sperm. 
 40% 80% 
Bovipure  200µl 400µl 
Bovidilute  300µl 100µl 
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Appendix C: Freezing and thawing media recipes  
H199 + 10%FCS 
9 ml H199 
1 ml FCS 
 
Base media (BM) + 20% FCS 
16 ml H199  
4 ml FCS  
 
Warming solution 1 (1M sucrose in base media)  
17 g sucrose (Sigma S1888)  
30 ml Base media  
Dissolve and make up to 50 ml with BM  
 
 
Warming solution 2 (0.5M sucrose with BM)  
20 ml 1M sucrose in BM (warming solution 1)  
20 ml Base media  
 
 
Equilibration media  
8.5 ml base media  
750 µl DMSO (Sigma D2650)  
750 µl Ethylene Glycol (Sigma 102466)  
 
Vitrification solution (BM + 05M sucrose + 15% DMSO + 15% EG)  
7 ml 0.5M sucrose in BM (warming solution 2)  
1.5 ml DMSO (Sigma D2650)  




Appendix D: Transmission electron microscopy processing recipes 
0.2 M Cacodylate buffer (NaCac)  
21.4g sodium cacodylate-trihydrate (ProSciTech, Australia)  
500 ml H20 
pH 7.4 
 
0.15M NaCac + 2mM CaCl2 
75 ml of 0.2M cacodylate buffer  
25ml H2O  
 
0.15M NaCac 
50 ml of 0.1M NaCac  
25 ml H2O 
 
2% Glutaraldehyde in 0.10M NaCac  
1 ml of 12.5ml glutaraldehyde from a freshly opened vial (ProSciTech Cat#C002), Australia) 
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6.25 ml 0.2M NaCac 
5.25 ml H2O  
 
3% Agarose 
0.3g Low melting point Agarose (Sigma Cat#A9414, Missouri, USA)  
10 ml of 0.15M NaCac (no CaCl2) 
Heat to 450C to dissolve, aliquot into 5ml lots, store in fridge  
 
4% Osmium tetroxide stock  
1g Osmium tetroxide (ProSciTech Cat#C0101)  
25 ml H2O  
Takes a few days to dissolve, make in glass bottle covered with foil and store in a sealed glass 
jar in a fume hood.  
 
1% Osmium tetroxide in 0.1M NaCac  
1 ml of 4% osmium in H2O  
2 ml 0.2M NaCac  
1 ml H2O 
 
2% Uranyl Acetate en bloc stain (saturated)  
0.1g uranyl acetate (ProSciTech)  
4 ml H2O 
 
Agar 100 resin  
 Weight (g) Volume (ml)  
Agar 100 resin  24.0 20.5 
Dodecenylsuccinic anhydride (DSSA) hardener 16.0 17.2 
Methyl nadic anhydride (MNA) hardener 10.0 8.5 
Benzyldimethylamine (BDMA) accelerator (2.5%)  1.25 1.2 
 
 
 
 
 
 
 
 
 
 
 
 
